Photodynamic Activity Of Chloro(5,10,15,20-tetraphenylporphyrinato) Indium(iii) by Da Silva A.R. et al.
Article 
J. Braz. Chem. Soc., Vol. 19, No. 3, 491-501, 2008.
Printed in Brazil - ©2008  Sociedade Brasileira de Química
0103 - 5053  $6.00+0.00
*e-mail: rjorge@iqm.unicamp.br
Photodynamic Activity of Chloro(5,10,15,20-tetraphenylporphyrinato)indium(III)
André R. da Silva,a Alessandra C. Pelegrino,b Antonio C. Tedescob and Renato A. Jorge*,a
a Departamento de Físico-Química, Instituto de Química, Universidade Estadual de Campinas,  
CP 6154, 13084-971 Campinas-SP, Brazil
b
 Departamento de Química, Faculdade de Filosofia Ciências e Letras, Universidade de São Paulo,  
14040-901 Ribeirão Preto-SP, Brazil
A atividade fotodinâmica do cloro(5,10,15,20-tetrafenilporfirinato) de índio(III) (InTPP) in 
vitro foi investigado para possível uso em terapia fotodinâmica (PDT). O rendimento quântico de 
oxigênio singlete do InTPP (Φ∆ = 0,72) em DMSO foi maior que da 5,10,15,20-tetrafenilporfirina 
(TPP) (Φ∆ = 0,52). Os sítios de ligação entre os fotossensibilizadores e albumina bovina (BSA) 
são independentes e com células vermelhas de sangue humano (RBC) são cooperativos, com um 
e quatro sítios de ligação por molécula, respectivamente. As constantes de associação com BSA 
são (1,15 ± 0,07) × 105 e (2,6 ± 0,1) × 104 L mol-1 e com RBC são (2,40 ± 0,05) × 107 L mol-1 e 
(7,2 ± 0,2) × 104 L mol-1 para InTPP e Photofrin®, respectivamente. O InTPP foi mais eficiente 
do que Photofrin® em fotooxidar L-triptofano (Trp) e BSA quando maiores concentrações dos 
fotossensibilizadores foram utilizadas (acima de 14 µmol L−1). O InTPP foi 1,37 a 1,5 vezes mais 
eficaz em fotooxidar as RBC do que Photofrin®. Nossos resultados indicam que o InTPP pode 
ser usado para estudos futuros de PDT. 
Photodynamic activity of chloro(5,10,15,20-tetraphenylporphyrinato)indium(III) (InTPP) in 
vitro was investigated for possible use in photodynamic therapy (PDT). The quantum yield of singlet 
oxygen generation in DMSO of InTPP (Φ∆ = 0.72) was higher than 5,10,15,20-tetraphenylporphyrin 
(TPP) (Φ∆ = 0.52). Binding sites between photosensitizers and bovine serum albumin (BSA) are 
independent while binding sites with human red blood cells (RBC) are cooperatives, with one 
and four binding sites per molecule, respectively. Binding constants with BSA are (1.15 ± 0.07) 
× 105 and (2.6 ± 0.1) × 104 L mol-1 and with RBC are (2.40 ± 0.05) × 107 L mol-1 e (7.2 ± 0.2) × 
104 L mol-1 for InTPP and Photofrin®, respectively. InTPP was more efficient than Photofrin® 
in the photooxidation of L-tryptophan(Trp) and BSA when higher concentrations (14 µmol L−1) 
of photosensitizers were used. InTPP was 1.37-1.5 times more effective in the photooxidation of 
RBC than Photofrin®. Our results indicate that InTPP should be used in future studies of PDT.
Keywords: indium(III)-meso-tetraphenylporphyrin, PDT, quantum yield, hemolysis, singlet 
oxygen
Introduction
Photodynamic therapy (PDT) is a therapeutic modality 
used in the treating neoplastic diseases and in other 
applications, such as sterilizing freshly frozen plasma, 
treating actinic keratosis, choroidal neovascularization 
from macular degeneration and pathological myopia.1-7 
Photodynamic activation has also found use for treatment 
of wastewater and sunlight-activated herbicides and 
insecticides.8,9 In the treatment of neoplastic diseases, 
photosensitizers are normally used in special drug delivery 
systems, which preferentially accumulate in the target cells. 
Subsequent irradiation of the lesion with an adequate light 
source leads to the destruction of the target cell by the 
local generation of toxic radicals (type I mechanism) and/
or singlet oxygen (type II mechanism).1-3 
Some photophysical properties have been identified as 
essential in an efficient sensitizer for PDT, such as a long 
lifetime of the excited triplet state, low fluorescence quantum 
yield (Φf), deactivation directed by the singlet excited state, 
and a high quantum yield of singlet oxygen generation.1–3 
The success of PDT requires an optimal correlation between 
the physical and chemical parameters of the photosensitizer, 
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its pharmacological properties (pharmacokinetic and 
pharmacodynamic behaviors in biological tissue), and its 
phototherapeutic properties in vivo.10 In this context, new 
designs of photosensitizing agents have been studied, in 
which their chemical properties were modified, including 
the size of the macrocycle and the nature of the peripheral 
groups.11–15 The coordination of the central metal ion in 
phthalocyanines and porphyrinic structures influences the 
formation of reactive oxygen species and the mechanism 
of target cell destruction.16–17 Rosenfeld et al.18 and Chen et 
al.19 showed that the presence of indium(III) in the core of a 
series of pyropheophorbide enhanced their photosensitizing 
efficiency in vitro and in vivo. The overall lipophilicity of 
the macrocycle plays a significant role in the photodynamic 
efficiency of sensitizers.18 Jezek et al.20 showed that lower 
doses of TPP-loaded liposome were more efficient in vivo 
than hydrophilic meso-tetra(4-sulfonatophenyl)porphine 
(TPPS4) or commercial Photosan-3®. 
The general objective of the present study was to 
evaluate the photosensitizer activity of InTPP in vitro. 
The specific aims were: (i) determination of Φ∆, Φf, and 
the triplet state lifetime (τT) of InTPP and comparison of 
these photophysical properties with those of the free-base 
porphyrin (TPP), to obtain information about the effect 
produced by the formation of the metal complex with 
In(III); (ii) comparison of the efficiency of InTPP with that 
of Photofrin® in photooxidation of Trp, BSA, and RBC; 
and (iii) correlation of BSA and RBC affinities of InTPP 
and Photofrin® with their photosensitizer activities.
Experimental
Reagents 
InTPP and 5,10,15,20-tetrakis(4-N-methylpyridyl)
porphyrin (TMPyPH2; pharmaceutical grade, > 95% 
pure) were purchased from Frontier Scientific Inc 
(Logan, UT, USA). Photofrin® (haematoporphyrin 
derivative, pharmaceutical grade) was from Axcan 
Pharma Inc. (Mont-Saint-Hilaire, Quebec, Canada). 
BSA, Trp, polyoxyethylene sorbitan monolaurate 
(Tween® 20), N,N-dimethylformamide (DMF), and 
ethylenediaminetetraacetic acid (EDTA) were purchased 
from Sigma Chemical Company (St Louis, MO, USA) 
and NaCl, KCl, Na2HPO4•7H2O, and NaH2PO4•H2O were 
purchased from Merck (Whitehouse Station, NJ, USA). 
The RBC used in the hemolysis assays were donated by 
the Hospital de Clínicas of the Universidade Estadual de 
Campinas, according to the Ethical Human Protocols of 
the Faculdade de Ciências Médicas of the Universidade 
Estadual de Campinas. 
 Steady-state measurements
Electronic absorption measurements of InTPP 
(1.0  µmol L−1) and TPP (1.0 µmol L−1) were made using 
samples in DMSO, with a Hewlett Packard 8453A Diode 
Array Spectrophotometer. Fluorescence quantum yields 
were determined using an ISS® PC1 photon counter with 
TPP in DMSO as the standard, with Φf = 0.13.21 Absorbances 
of the standard (0.03 µmol L−1, λ
excitation = 418 nm) 
and InTPP (0.03 µmol L−1, λ
excitation = 426 nm) were lower 
than 0.05 to avoid internal filter effects. The fluorescence 
quantum yield for each sample was measured using the 
ratio method described by Eaton.22 
Triplet state lifetime measurements
Triplet state lifetime measurements of InTPP in DMSO 
were made using a laser flash photolysis spectrometer, 
which allowed the simultaneous capture of the transient 
absorption spectrum (λ = 300-800 nm) and the transient 
kinetics at a single wavelength. Solutions were deaerated by 
nitrogen bubbling. The InTPP concentrations (27 µmol L−1) 
at 355 nm were adjusted in order to obtain an absorbance 
on the order of 0.4, what assure a good population of the 
excited state and all further process. The triplet state was 
studied by laser flash photolysis, as previously described, 
using a system reported in detail elsewhere.23,24 Briefly, the 
system uses the third harmonic (355 nm) of an Nd-YAG 
laser. The pulse length was 8 ns, the beam diameter incident 
on the sample was 6 mm, and the repetition rate was 10 Hz. 
The pulse energy was typically 30 mJ per pulse as measured 
with a Field Master power meter with L-30V head. A 
400 W tungsten-halogen lamp was used as the probe. The 
lamp beam is collimated (1 mm in diameter) through the 
sample in the cell holder, which is held in a cuvette 1 cm 
pathlenght. The growth-decay kinetics were measured at 
a single wavelength using a monochromator (M300 from 
Bentham), and a photomultiplier (Hamamatsu, model 
R928P). Transient decays were averaged using a Tetronix 
TDS 340A digital oscilloscope. The stored digitized kinetic 
decays were transferred to a personal computer (PC) for 
analysis with software supplied by Edinburgh Instruments 
(Livingston, UK). Pheophorbide-a (10 µmol L−1) in DMSO 
was used as the standard to evaluate the triplet lifetime 
(100 µs).25
Quantum yield of singlet oxygen generation
Singlet oxygen measurements were based on direct 
determination by infrared luminescence measurements at 
1270 nm, using a system reported in detail elsewhere.24 The 
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Φ∆ measurements for InTPP were carried out in DMSO, 
using pheophorbide-a in deuterated ethanol as the reference 
(Φ∆= 0.59)26. The absorbance of InTPP (27 µmol L-1) and 
pheophorbide-a (10 µmol L-1) was 0.4 at 355 nm. The 
solutions were saturated with high-purity O2 for 40 min 
before the measurements were made.
The apparatus used in this procedure is the same as that 
described for the triplet excited state, with small changes. 
The excitation laser and setup was the same. However, 
a Germanium Detector model 823A from North Coast 
Scientific Corporation (Worcestershire, UK-England), 
operating in a nitrogen-cooled system substituted the 
photomultiplier. The signal was transferred to the same 
digital oscilloscope and analysis was carried out with a 
software supplied by Edinburgh Instruments. A silicon 
filter was used to avoid any fluorescence signal interferred 
with the singlet oxygen luminescence. Measurements were 
conducted using different concentrations and different laser 
intensities and the observed linearity with zero intercept 
rules out unwanted phenomena such as ground-state 
depletion, excited-state self-annihilation or multiphotonic 
absorption.
Dimerization constants of InTPP 
InTPP is a hydrophobic compound and the 
dimerization constant of InTPP (KD) was determined by 
the Margalit method.27 This method linearizes the data 
from measurements of fluorescence intensity (F) and 
has two basic hypotheses: (a) dimers are the dominant 
aggregates at low concentrations; (b) only the monomer 
fluoresces, since porphyrins are known to produce 
dimers and aggregates that are non-fluorescent.27 KD was 
calculated by equation 1:
 (1)
where [InTPP]total = [InTPP]monomer + [InTPP]dimer. k is a 
proportionality constant, F = k[InTPP]
monomer
, and KD was 
determined by the slope of the straight line of equation 
1. The absorbance of InTPP (0.01-0.04 µmol L−1) at the 
excitation wavelength were lower than 0.05 to assure a 
direct proportionality between the emitted fluorescence 
intensity and the concentration of the monomer. InTPP was 
dissolved in DMF and them added to an aqueous solution 
containing phosphate-buffered saline (PBS; pH 7.4), and 
Tween 20 (0.45 mmol L−1). The final concentration 
of DMF was 5% v:v. The concentration of Tween® 20 
was kept above its critical micellar concentration (CMC; 
0.04 mmol L−1).28 Samples contained in a 1 cm pathlength 
quartz cuvette were excited at 427 nm and the fluorescence 
emitted by InTPP was recorded between 580 nm and 700 
nm. The experiments were carried out in triplicate.
Irradiation system and light dose absorbed by photo-
sensitizers
The irradiation system consisted of a mercury 
lamp (Phillips® HPLN 80W) cooled by a water jacket 
compartment, which absorbs the infrared radiation emitted 
by the lamp, and an Oriel BG 38 filter, which allows the 
passage of radiation between 400 nm and 600 nm. The 
radiaton emitted (I
o
) was 6.27 mW cm−2 as measured with a 
spectroradiometer (LI-1800, LI-COR Instruments, Lincoln, 
NE, USA). The vials with solutions of Trp, BSA and RBC 
were placed 5 cm from the lamp and were then irradiated 
for the desired time. The solutions were bubbled with O2 
to ensure saturation. The value of the irradiance absorbed 
by the photosensitizer solutions at each wavelength (Iphoto,λ) 
was calculated from the intensity of the incident light (I0) 
by Beer’s law:
 (2)
where A is the absorbance of InTPP and Photofrin® 
(0.3-42.0 µmol L−1). A was measured at each wavelength 
before irradiation of the samples. The total irradiance 
absorbed by the photosensitizer (Iphoto) was calculated as:
 (3)
The dose of light absorbed by the photosensitizer in 
order to oxidize the substrate (in J cm−2) was calculated 
as Iphoto × t, where t is the irradiation time required for 
oxidation (in seconds).
 Trp and BSA photooxidations 
Solutions of Trp (150 µmol L−1) and BSA (23.5 µmol L−1) 
in phosphate-buffered saline (PBS, pH 7.4) DMF (5% v:v), 
and Tween 20 (8.94 mmol L−1), containing InTPP or 
Photofrin® (1.0–42.0 µmol L−1) were irradiated in a total 
volume of 3 mL. The emission fluorescences (F) of Trp 
and BSA were monitored using an ISS® PC1 photon 
counting spectrofluorimeter. Trp and BSA excitation was 
at 280 nm and F was measured at 355 nm and 324 nm, 
respectively. Plots of ln F against time for Trp and BSA 
gave a straight line from which the rate constant was 
calculated. The half-life (t50) and dose of light absorbed to 
oxidize 50% of the substrate were calculated as described 
in the previous section. 
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Hemolysis of RBC
Photohemolysis can be measured by two proce dures: 
hemolysis during irradiation (“continuum” photo-
hemolysis, CPH) or postirradiation hemolysis (“delayed” 
photohemolysis, DPH). In this work, CPH was 
measured.
Human blood of single donator was collected 48 h 
before the hemolysis assays in a tube containing EDTA, 
which was used as an anticoagulant. The tube was kept 
in a freezer until the moment of use. The serum was 
separated from the erythrocytes by centrifugation at 780 × g 
for 10 min. The RBC were washed with NaCl solution 
(0.85% m:v) using three times the blood volume and then 
the cells were centrifuged at 1760 × g for 10 min to reduce 
the anticoagulant and serum residues. This procedure 
was repeated three times. RBC solutions (4 mL and 
1.89 × 1010 cells L−1) containing PBS (pH 7.4), Tween 20 
(0.45 mmol L−1), DMF (1.6% v:v) and InTPP or Photofrin® 
(0.3-23.8 µmol L−1) were irradiated for 60 min using the 
photooxidation system previously described. Photofrin®, 
which is a water-soluble drug, was directly solubilized in 
the solution containing PBS, Tween 20 and DMF while 
InTPP was initially solubilized in DMF and later added 
to the solution containing PBS, Tween 20® and DMF. 
Samples of 550 µL were collected at intervals of 10 min 
and centrifuged at 500 × g for 5 min. The supernatant 
was analyzed using a Hewlett Packard 8453A Diode 
Array Spectrophotometer at a wavelength of 542 nm to 
measure the oxyhemoglobin chromophore released from 
the erythrocytes as a result of the destruction of the RBC 
by the photodynamic action of the photosensitizer. The 
percentage hemolysis achieved with the photodynamic 
action was calculated by equation 4: 
  (4)
where A1 is the absorbance of the supernatant from 
the solution that contains the photosensitizer, A2 is the 
absorbance of the control (without photosensitizer), and AT 
is the absorbance of total hemolysis, which is calculated 
from the lysis of the erythrocytes with an ultrasound cell 
disrupter (Ney ULTRAsonik ultrasonic system). 
 Binding of sensitizers to BSA and erythrocytes 
Suppose that a protein P with n binding sites reacts with 
a low molar mass ligand L. The microscopic equilibriums 
may be defined as follows:
 (5)
 (6)
 (7)
[L]bound = [PL1] + 2 [PL2] + ……. + n [PLn] (8)
[P]total = [P] + [PL1] + ……… + [PLn] (9)
[PL1] = K1[P][L], [PL2] = K1K2[P][L]2, [PLn] = 
K1K2…..Kn-1Kn[P][L]n  (10)
The mean ratio of [L]bound to the total concentration of 
the P cells (cell number L−1) is:
 (11)
Therefore, from the last equations (8), (9), (10) and (11) 
ν can be rewritten as:
 (12)
For highly cooperative binding, the association of 
a molecule L on one site of P may thermodynamically 
influence the binding with all the other sites. In these 
conditions, only the concentrations of P and PL
n
 are not 
negligible and equation (12) can be simplified to:29
 (13), where K = K1K2…..Kn
The apparent binding association constant (K) between 
photosensitizer and erythrocytes was calculated by using 
equation 13. One mL of RBC at a total concentration 
([Ptotal]) of 1.1 × 1011 cells L−1 in a solution containing 
PBS (pH 7.4), Tween® 20 (0.45 mmol L−1) and DMF 
(1.6% v:v), were incubated in the dark in the presence 
of photosensitizer concentrations ranging from 1.0 to 
8.0 µmol L−1 for 30 min and then centrifuged at 500 × g for 
5 min. The concentration of the free photosensitizer [L] was 
determined spectrofluorimetrically, based on a previously 
constructed calibration curve. [L]bound in equation 11 was 
calculated by: [L]bound = [L]total - [L]. 
Equation 13 may be rearranged to:
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 (14)
The left side of equation 14 can be evaluated from 
spectrofluorimetric data of proteins, because:
 (15)
where F
o
 and F are fluorescence emissions of protein in the 
absence and presence of photosensitizer:
 (16)
Equation 16 may be rearranged to:
 (17)
The apparent binding association constant (K) 
between photosensitizer and BSA was calculated by 
using the “double-logarithmic” plot of equation 17. 
Three mL of BSA (20 µmoles L−1) in PBS (pH 7.4), 
Tween® 20 (0.45 mmol L−1) and DMF (1.6% v:v) was 
titrated spectrofluorimetrically by adding InTPP or 
Photofrin® in PBS (pH 7.4), Tween® 20 (0.45 mmol L−1) 
and DMF (1.6% v:v) from a concentrated stock. The 
photosensitizer concentrations in the cuvette ranged from 
3.0 to 20.0 µmol L−1. BSA excitation was made at 280 nm 
and emission fluorescence was measured at 324 nm. 
In equation 17, [L] should be the free concentration of 
the InTPP or Photofrin®, which is unknown. So, the total 
concentration of photosensitizer added in each aliquot 
of titration was used as [L]. The parameters n and K of 
equations 13 and 17 were evaluated using the software 
Origin® 7.5 (OriginLab Inc, Northampton, MA, USA). 
Results and Discussion 
Photophysical results
The structures of InTPP and TPP and the absorption 
spectra of the InTPP and TPP in DMSO are shown in 
Figures 1 and 2, respectively.
InTPP presents three characteristic absorption bands in 
the visible region. The most intense band at 427 nm (B-band) 
is related to the transition from orbital a1u to a degenerated 
orbital eg (referring to a vibronic transition ν0 → ν0). The other 
two bands (560 and 600 nm, Q-bands) are due to the transition 
from orbital a2u to orbital eg (referring to a vibronic process 
ν0 → ν0 and ν0 → ν1). The B-band for TPP is located at 418 nm 
while the Q-bands are located at 516 nm, 550 nm, 590 and 
646 nm. The four bands for TPP are related to the presence 
of extra two hydrogens in the free base porphyrin that lead to 
a reduction of the overall porphyrin symmetry from the D4h 
type of metalloporphyrins to D2h.30 The structural changes in 
the basic structure of InTPP compared with those in TPP lead 
to a blue shift in the peak position of the long-wavelength 
Q band (646 nm for TPP versus 600 nm for InTPP).21 This 
blue shift is attributable to a distortion of the ligand plane 
caused by the central ion,31,32 and is also considered to be 
a measure of the degree of interaction between the central 
ion and the conjugated system.29 The transient absorption 
spectrum obtained with laser flash photolysis of InTPP in 
DMSO is shown in Figure 3. The spectrum has a maximum 
transient absorption at 450 nm and is very similar to the 
Figure 1. Computer-drawn structures of TPP and InTPP. These were 
generated with the molecular modeling program HyperChem 6.03 using 
the molecular mechanic method, and the model MM+ to parameterize 
the force field that determine the potential energy as a function of the 
molecular configuration. The 18-membered porphine ring of TPP are in 
plane and the four phenyl groups are not. The presence of In-Cl causes 
the 18-membered porphine ring of TPP to move out of the plane.
Figure 2. Electronic absorption spectra of InTPP (1.0 µmol L-1) and 
TPP (1.0 µmol L-1) in DMSO. Q bands were 10 × enhancements in all 
peaks.
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triplet–triplet absorption of metallotetraphenylporphyrins 
with diamagnetic central.33–35 The triplet lifetime of InTPP 
(1.58 ± 0.01 µs) is of the same order of magnitude as those 
usually found for porphyrins (2.27 µs) in nitrogen bubbling 
methanol solutions. A similar result was obtained by Hoshino 
et al.,34 with a value of 1.90 µs for the triplet lifetime of 
InTPP in an aerated methanol solution and a transient peak 
maximum at 460 nm. These values are sufficient to allow 
an efficient energy transfer process to molecular oxygen, 
leading to the production of singlet oxygen. 
Table 1 presents the photophysical properties of InTPP 
and TPP. The extinction coefficient (ε) values showed that 
InTPP absorbs more photons than TPP in the Q bands. The 
Φf obtained for InTPP in DMSO (0.05) is in agreement with 
results reported in the literature for ethanol and benzene 
solutions.36 The Φf of TPP in DMSO (0.13) was greater 
than that of InTPP (0.05). This was also observed for the 
fluorescence lifetime of InTPP (0.8 ns in ethanol and 0.5 ns in 
benzene) compared with that of TPP (10.1 ns in ethanol and 
12.4 ns in benzene).36,37 This behavior can be explained by the 
spin-orbit coupling induced by In(III), favoring the population 
of the triplet state. The results for Φ∆ show that InTPP in 
DMSO is a good generator of singlet oxygen compared 
with other derivatives of meso-tetraphenylporphyrin.38,39 
Chloro(5,10,15,20-tetraphenylporphyrinato)gallium(III) 
(GaTPP), for example, has a Φ∆ value of 0.85 in toluene.40 
For InTPP, the Φ∆ value measured in DMSO (0.72) is higher 
than the Φ∆ value of TPP (0.52) in the same solvent.21 The 
Φf of TPP in DMSO is 2.6 times greater than that of InTPP, 
which leads to a higher deactivation of the singlet excited 
state and a slower intersystem crossing to the triplet state. 
The Φ∆ of InTPP in DMSO is 1.38 times greater than that 
of TPP. It is known that the quantum yield and lifetime of S1 
emissions are reduced with increases in the atomic number 
of the central metal ion.20 The enhancement of spin–orbit 
coupling in the atoms of higher atomic number results in 
the acceleration of the intersystem crossing S1→T1 (heavy-
atom effect), increasing the triplet quantum yield (ΦT). The 
τT value of TPP in DMSO was obtained from equation 
(3) of Korinek et al.21 at same concentration of InTPP (27 
µmol L-1) used for measuring τT of InTPP. The τT of TPP is 
50 times greater than InTPP. Φ∆ depends of the absorption 
of light, the ΦT, on the trapping efficiency of the triplet state 
by molecular oxygen within its lifetime and energy transfer 
from the triplet state to molecular oxygen.41 We observed 
that although the lifetime of the triplet state of InTPP is 
lower than for TPP the quantum yield of the singlet oxygen 
of InTPP is larger than for TPP, suggesting from this data 
that the triplet state lifetime of 1.58 µs of InTPP is larger 
than that for the trapping process.
Dimerization of InTPP 
Margalit’s plot (equation 1) was linear in the interval 
from 0.005 to 0.04 µmol L−1 InTPP (results not shown) 
indicating that for concentrations above of 0.04 µmol L-1 
the formation of dimers and other aggregates occurs. 
The dimerization constant of InTPP was (4.7 ± 0.2) × 
107. The KD of InTPP was 110 times greater than the 
KD of deuteroporphyrin IX and mesoporphyrin IX.27 
Deuteroporphyrin IX and mesoporphyrin IX contain two 
carboxyls in their structures and the polarity of these 
molecules diminishes the dimerization constant. Because 
InTPP does not possess polar groups, its dimerization 
constant is higher than those of these two porphyrins. 
Trp and BSA photooxidations and binding of sensitizers 
to BSA
There are many papers in the literature that show the 
efficacy of TPP in photooxidizing biomolecules.42,43 Faustino 
Table 1. Photophysical properties of InTPP and TPP 
Sensitizer Solvent λ
max
/nm ε
max
/
(L mol-1 cm-1)
τ /µsa φfa Φ∆b
InTPP DMSO 427, B 
560, Q 
600, Q
799,973d 
26,779 
16,189
1.58d 0.05d 0.72d
TPP DMSO 418, B 
516, Q 
550, Q 
590, Q 
646, Q
354,480d 
14,084 
5,814 
3,650 
2,442
79.1e 0.13f 0.52e
anitrogen bubbling solutions; boxygen-saturated solutions; B, B-band; 
Q, Q-band; dthis work; eref 21; fref 61.
Figure 3. Transient absorbance spectrum of InTPP with excitation at a 
wavelength of 355 nm (30 mJ per pulse). 
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et al.44,45 evaluated the meso-tetraphenylporphyrin dimer 
derivative as a potential photosensitizer in PDT. Recently, 
Pegaz et al.46 showed that TPP-loaded nanoparticles exhibited 
more photothrombic efficiency than free TPP. The presence 
of the gallium atom in the core of TPP increased the quantum 
yield of singlet oxygen generation by 31%.40,47 This effect 
could cause a higher photooxidation efficiency. In the same 
way, it is expected that InTPP is more efficient than TPP due 
to the heavy atom effect that is present in both InTPP (as 
shown in the previous section) and GaTPP. Thus, we decided 
that it is more significant to compare the photooxidation 
induced by InTPP with that of the drug approved by FDA 
and already being used the clinical treatments. 
The photooxidation of tryptophan was used to compare 
the photodynamic efficiencies of InTPP and Photofrin® 
in the oxidation of a simple biomolecule. The light 
dose required to photooxidize 50% of the biomolecule 
shows that InTPP and Photofrin® present approximately 
the same effectiveness in photooxidizing the amino 
acid at photosensitizer concentrations in the range of 
5.9–14.0 µmol L−1 (Figure 4). However, InTPP is more 
efficient than Photofrin® when higher concentrations 
(14.0–41.4 µmol L−1) of photosensitizer were used in the 
experiment. 
In the oxidation of proteins by the photosensitizers 
the chains are degraded because of the presence of amino 
acids, such as cysteine, histidine, methionine, tryptophan, 
and tyrosine. The work of Silvester et al.48 determined 
that BSA photooxidation using hematoporphyrin or 
tetramethylpyridiniumporphyrin occurs at two different 
specific sites of the protein: at Trp-134 and/or Trp-214 
residues and at the Cys-34 residue, respectively. 
Radicals were generated at tertiary carbons in tryptophan 
photooxidation and RS radicals were formed in cysteine 
photooxidation. In the case of tryptophan, the radical 
formation coincided with a fluorescence decrease in 
BSA.48 The photodynamic efficiency of InTPP to oxidize 
proteins was investigated using BSA solutions, which were 
irradiated in the presence of different concentrations of the 
indium porphyrin. The results were compared with those for 
Photofrin®. Figure 5 shows the dose of light absorbed to 
photooxidize 50% of BSA. The data show that Photofrin® is 
more efficient than InTPP at photosensitizer concentrations 
in the range of 1.6-14.0 µmol L−1. Nevertheless, InTPP is 
more efficient than Photofrin® at concentrations in the 
range 14.0-27.0 µmol L−1. 
The differences in the observed photooxidation 
efficiencies of InTPP and Photofrin® may be related to the 
aggregation of these compounds and to differences in the 
structures of BSA and Trp. Photofrin® is present in aqueous 
solution as monomers, dimers, trimers and other oligomeric 
species. A ratio of 14:19:67 for monomers, dimers and 
oligomers has been estimated for Photofrin®.49 The 
largest oligomer of Photofrin® contains nine monomeric 
units.50 As shown previously, InTPP dimerizes under the 
conditions of our experiments (above 0.04 µmol L-1). 
Even if trimers and other oligomers of InTPP occur, the 
fraction of large oligomers in Photofrin® at the higher 
concentrations is probably greater than that for InTPP, 
which would diminish the formation of singlet oxygen in 
the Photofrin® relative to InTPP, thus causing a reduction 
in the photodynamic efficiency of Photofrin® relative to 
that of InTPP in the photooxidation of Trp and BSA at these 
higher concentrations.
Serum albumin is a carrier for photosensitizers.51 Its 
binding affinity for drugs can play an important role in 
Figure 4. Photosensitizing activity of InTPP or Photofrin® with trypto-
phan (175 µmol L−1). Data represents mean ± SD of three independent 
experiments.
Figure 5. Photosensitizing activity of InTPP or Photofrin® with BSA 
(23.5 µmol L−1). Data represents mean ± SD of three independent 
experiments.
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photodynamic efficiency. The photosensitizers can be 
bound with amino acids of serum albumin. However, only 
tryptophan presents a strong emission of fluorescence 
when part of a protein chains.52 Thus, the interactions 
between InTPP or Photofrin® and BSA was studied by 
the fluorescence of tryptophan. The number of sites on 
the BSA capable of binding photosensitizers, derived 
from the slope of the linear plot of equation 17 (figure not 
shown) were (1.06 ± 0.06) and (0.97 ± 0.05) for InTPP 
and Photofrin®, respectively. The binding constants for 
BSA using intercepts of the linear plot of equation 15 
were (1.15 ± 0.07) × 105 and (2.6 ± 0.1) × 104 L mol-1 for 
InTPP and Photofrin®, respectively. The binding sites 
are independent and identical and in InTPP are stronger 
than Photofrin®. These results support the photodynamic 
efficiency observed with Photofrin®, as expected for 
its known photosensitizer properties, and for InTPP as 
shown in Figure 5. However, the correlation between 
photodynamic activity and affinity with BSA occurs when 
higher concentrations (14.0 µmol L-1) of photosensitizers 
were used. This behavior could be explained as K is a 
practical constant and not a thermodynamic equilibrium 
constant. The value of K measures the interaction of 
photosensitizer monomer-BSA and all the other interactions 
such as photosensitizer dimer-BSA, photosensitizer trimer-
BSA, and photosensitizer oligomer-BSA. Therefore K 
is an average value of all these interactions, while the 
photodynamic efficiency is directly related with the 
quantum yield of singlet oxygen generation that can be 
diminished by the association of sensitizer molecules with 
oligomers, whose concentrations vary with the state of 
aggregation of the sensitizer. Our results are concordant 
with others reported in the literature. K and n values 
for chlorine e6-BSA are 1.62 × 105 L mol-1 and 1.086, 
and between riboflavin-BSA are 8.5 × 104 L mol-1 and 
1.10.53,54 K for norharmane (NHM), an efficient cancer cell 
photosensitizer, and BSA is 1.33 × 104 L mol-1.55 
Erythrocyte hemolysis and binding of sensitizers to eryth-
rocytes
RBC have been used as a model to study the ability of 
compounds to induce a photooxidation process in cells in 
vitro, because of the ease and inexpensiveness of the assays. 
RBC hemolysis can occur from an osmotic–colloidal 
process, which results in salt and water retention by the 
cells.33,56 This causes the loss of membrane-selective 
permeability, resulting in cell swelling and the eventual 
rupture of the membrane. Hemolysis can also occur from 
the photooxidation of intrinsic proteins located in the 
membrane, which are bound to phospholipids, and/or by 
the photooxidation of the unsaturated phospholipids that 
constitute the erythrocyte membrane, causing the formation 
of pores and an increase in phospholipid mobility. This 
causes membranes to rupture, with the consequent release 
of oxyhemoglobin from the erythrocytes. 
Surfactants also cause erythrocyte hemolysis through 
lipid and protein solubilization when the surfactant 
concentration is near or above the CMC. At lower 
concentrations, monomeric species of the surfactant interact 
with the hydrophobic region of the lipid bilayer. The 
nonpolar region of the surfactant is located within the lipid 
bilayer and the polar head group is located at the surface 
of the membrane. This causes an increase in membrane 
permeability, but without rupture. Therefore, care was taken 
to establish the percentages of Tween® 20 (0.45 mmol L−1) 
and DMF (1.6% v:v) in the erythrocyte solutions, to 
minimize the hemolysis caused by the surfactant and the 
organic solvent itself. 
Using the preestablished conditions described above, 
RBC solutions with different concentrations of InTPP 
and Photofrin® (0.3-23.8 µmol L−1) were irradiated with 
a mercury lamp. Figure 6 shows a typical photohemolysis 
curve with a sigmoidal shape, as reported by other 
researchers.57,58 It can be seen in Figure 6 that Photofrin® 
required a longer times than InTPP to photooxidize RBC 
at all concentrations.
Table 2 presents irradiation times and light doses 
absorbed by the photosensitizers to inactivate 50% of the 
cell population. The light doses values indicate that InTPP 
was 1.5–1.37 times more effective in the photooxidation 
of RBC than Photofrin®, as the concentration of the 
photosensitizer was increased from 3.14 to 20.0 µmol L−1 
Figure 6. Delayed photohemolysis curves for human red blood cells 
(1.89 × 1010 cells L−1) photosensitized by InTPP or Photofrin®. Data 
represents mean ± SD of three independent experiments.
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of InTPP. Photoxidation did not occur when a lower 
concentration of Photofrin® was used (0.35 µmol L−1). 
Table 2 shows that there was a reduction in t50 when 
the concentration of InTPP was increased from 0.26 to 
6.4 µmol L−1. However, there was almost no change in t50 
when the concentration of InTPP was increased from 6.4 
to 20.0 µmol L−1, possibly due to the formation of larger 
oligomers at higher InTPP concentrations in the presence 
of RBC. There was also a decrease in the maximum 
percentage hemolysis from 100% to around 82% when 
higher concentrations of InTPP (6.4 and 20 µmol L−1) 
were used in the experiment. No changes were observed 
in the maximum percentage hemolysis when higher 
Photofrin® concentrations were used. Grossweiner et 
al.57 reported that, in porphyrin-binding experiments 
with RBC, the bound sensitizer fraction decreased as the 
total sensitizer concentration increased. This suggests 
that increases in the porphyrin concentration favor the 
aggregation of its molecules. Therefore, it is possible that 
the microenvironment of erythrocytes does not change the 
aggregation state of Photofrin®, but favors the formation 
of InTPP aggregates, which decreases the percentage 
hemolysis to around 82%.
Determination of the parameters n and K of equation 
13 and using the data shown in Figure 7 showed that 
there are four cooperative binding sites per cell, with 
association constants of (2.40 ± 0.05) × 107 L mol−1 and 
(7.2 ± 0.2) × 104 L mol−1 for InTPP and Photofrin®, 
respectively. These results show that InTPP has a higher 
affinity for erythrocytes than Photofrin®. The differences 
in the observed efficiencies could be associated with the 
affinity of the sensitizers for the erythrocyte membrane. 
Photodynamic activity of phthalocyanines was also 
observed to correlate with the affinity of the dye for 
the cell.59 The Davson–Danielli principle states that the 
ease with which a compound passes through the cellular 
membrane is proportional to its lipophilic character.60 
Therefore, the higher polarity of Photofrin® molecules 
weakens their interaction with the membrane. Our results 
indicate that, because of the higher affinity of InTPP for 
RBC compared with that of Photofrin®, a lower light 
dose is required for the indium porphyrin to inactivate 
50% of the cell population, which demonstrates the higher 
efficiency of InTPP.
Conclusions
The presence of the indium atom in the structure 
of meso-tetraphenylporphyrin causes a decrease in the 
fluorescence quantum yield because of the enhancement 
of spin–orbit coupling. This results in an acceleration of 
the intersystem crossing and a consequent reduction in the 
yield and lifetime decay of the S1 emission, which increases 
the quantum yield of singlet oxygen generation. InTPP was 
more efficient than Photofrin® in the photooxidation of Trp 
and BSA when higher concentrations of photosensitizer 
were used. The affinity of BSA for InTPP is high and 
plays an important role in photodynamic efficiency of 
InTPP. Erythrocyte photooxidation showed that InTPP is 
more efficient than Photofrin® in causing the hemolysis 
of RBC, probably because InTPP has a greater affinity for 
sites on the RBC than does Photofrin®, which results in 
shorter photohemolysis times for the indium porphyrin. 
Table 2. Irradiation times (t50) and light doses absorbed by the photosensitizers to inactivate 50% of the cell population 
[InTPP]/ 
(µmoles L −1)
t50/min Light doses/ 
(J cm−2)
[Photofrin®]/ 
(µmoles L−1)
t50/min Light doses/ 
(J cm−2)
0.26 61.0 ± 1.4 660 ± 50 0.31 * *
3.14 45.1 ± 1.6 3600 ± 200 3.73 88.5 ± 2.2 5400 ± 30
6.4 35.0 ± 1.2 4100 ± 200 7.6 65.8 ± 1.9 5900 ± 300
20.0 37.8 ± 2.1 6700 ± 400 23.8 55.5 ± 2.0 9200 ± 500
* Hemolysis was not observed.
Figure 7. Binding of the photosensitizers to the erythrocytes. Sensitizers 
(1.0–8.0 µmol L−1) were incubated in the dark for 30 min in solutions 
containing erythrocytes (1.1 × 1011 cells L−1), PBS (pH 7.4), Tween® 20 
(0.45 mmol L−1), and DMF (1.6% v:v). Data represents mean ± SD of 
three independent experiments.
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This is an interesting property of PDT, because with faster 
photooxidation rates, shorter irradiation times are required 
to destroy diseased tissues. The photophysical properties 
and photodynamic activity of InTPP in vitro suggest that 
InTPP should be explored in further studies of PDT. Studies 
to encapsulate InTPP for this purpose are in progress in 
our laboratory.
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